MedTrace Logo

REEV SENSE for Gait Analysis in Post-stroke Gait Impairment (SENS-AG)

NCT06234878 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2025-04-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical performance of the investigational REEV SENSE gait tracker to measure gait features in subjects with post-stroke gait impairment.

REEV SENSE is intended to be used by trained healthcare professionals as a simple procedure adapted to clinical routine.

The reference method for performance comparison will be motion capture.

Conditions

  • Stroke
  • Gait Disorders, Neurologic

Interventions

DEVICE

REEV SENSE

Gait analysis with an Inertial Measurement Unit (IMU) sensor

DEVICE

Motion capture system

Gait analysis with reflective markers and pressure sensors

Sponsors & Collaborators

  • REEV LLC

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-08
Primary Completion
2025-03-01
Completion
2025-04-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06234878 on ClinicalTrials.gov